Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti‐parkinsonian placebo response
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Placebo administration to Parkinson patients is known to induce dopamine release in the striatum and to affect the activity of subthalamic nucleus (STN) neurons. By using intraoperative single‐neuron recording techniques in awake patients, here we extend our previous study on STN recording, and characterize part of the neuronal circuit which is affected by placebos. In those patients who showed a clinical placebo response, there was a decrease in firing rate in STN neurons that was associated with a decrease in the substantia nigra pars reticulata (SNr) and an increase in the ventral anterior (VA) and anterior ventral lateral (VLa) thalamus. These data show that placebo decreases STN and SNr activity whereas it increases VA/VLa activity. By contrast, placebo non‐responders showed either a lack of changes in this circuit or partial changes in the STN only. Thus, changes in activity in the whole basal ganglia–VA/VLa circuit appear to be important in order to observe a clinical placebo improvement, although the involvement of other circuits, such as the direct pathway bypassing the STN, cannot be ruled out. The circuit we describe in the present study is likely to be a part of a more complex circuitry, including the striatum and the internal globus pallidus (GPi), that is modified by placebo administration. These findings indicate that a placebo treatment, which is basically characterized by verbal suggestions of benefit, can reverse the malfunction of a complex neuronal circuit, although these placebo‐associated neuronal changes are short‐lasting and occur only in some patients but not in others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network
Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002) · Science · doi:10.1126/science.1067176 · Cited by 1,488 · cited 1×
“…mechanisms at both the biochemical and cellular level, such as the activation of endogenous opioids (Levine et al. 1978; Amanzio & Benedetti, 1999; Petrovic et al. 2002; Zubieta et al. 2005; Wager et al. 2007), the decrease of pain transmission in some brain regions (Wager et al. 2004; Price et…”
BackgroundA Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
Price, D. D., Finniss, D. G., & Benedetti, F. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.113006.095941 · Cited by 1,146
Self-citationTHE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Amanzio, M., & Benedetti, F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00484.1999 · Cited by 899
Self-citationBenedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788 · cited 3×
“Pharmacological and non-pharmacological conditioning is known to enhance placebo responsiveness in a number of experimental models, such as pain, immune responses and hormone secretion (Benedetti et al. 2003; Colloca & Benedetti, 2006; Pacheco-Lopez et al. 2006).”
BackgroundSelf-citationPlacebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779 · cited 1×
“…biochemical and cellular level, such as the activation of endogenous opioids (Levine et al. 1978; Amanzio & Benedetti, 1999; Petrovic et al. 2002; Zubieta et al. 2005; Wager et al. 2007), the decrease of pain transmission in some brain regions (Wager et al. 2004; Price et al. 2007), the release…”
BackgroundPlacebo effects on human μ-opioid activity during pain
Wager, T. D., Scott, D. J., & Zubieta, J.-K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702413104 · Cited by 562 · cited 2×
“…level, such as the activation of endogenous opioids (Levine et al. 1978; Amanzio & Benedetti, 1999; Petrovic et al. 2002; Zubieta et al. 2005; Wager et al. 2007), the decrease of pain transmission in some brain regions (Wager et al. 2004; Price et al. 2007), the release of dopamine in…”
BackgroundIndividual differences in reward responding explain placebo-induced expectations and effects
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.028 · Cited by 466 · cited 1×
“…in some brain regions (Wager et al. 2004; Price et al. 2007), the release of dopamine in the striatum (de la Fuente-Fernandez et al. 2001; Strafella et al. 2006; Scott et al. 2007, 2008), and the modulation of the activity of single neurons in the subthalamic nucleus (STN) (Benedetti et al. 2004).”
BackgroundPlacebos and painkillers: is mind as real as matter?
Colloca, L., & Benedetti, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1705 · Cited by 465 · cited 1×
“Placebos are known to affect the brain in different conditions and different systems, such as pain, motor disorders, depression, the immune and endocrine systems (Benedetti et al. 2005; Colloca & Benedetti, 2005; Pacheco-Lopez et al. 2006; Benedetti, 2008a,b).”
BackgroundSelf-citation
Cited by
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Self-citationThe placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
Placebo and the New Physiology of the Doctor-Patient Relationship
Benedetti, F. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2012 · Cited by 492
Self-citationHow Placebos Change the Patient's Brain
Benedetti, F., Carlino, E., & Pollo, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.81 · Cited by 446
“These changes in the subthalamic nucleus were found to be associated with changes in neuronal activity in the substantia nigra pars reticulata and in the thalamus, which suggest that part of the basal ganglia and thalamic circuit is affected by placebos, as shown in Figure 3 (Benedetti et al, 2009).”
BackgroundSelf-citationSchedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323
“In their later study, those observations were expanded by recordings from thalamic nuclei and the substantia nigra (Benedetti et al., 2009), showing complex changes in the entire subthalamic-nigral-thalamic motor circuitry associated with the improvements following placebo administration (for a review, see Frisaldi et…”
BackgroundPlacebo Effects: From the Neurobiological Paradigm to Translational Implications
Benedetti, F. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.023 · Cited by 317
Self-citationThe Placebo Effect in Pain Therapies
Colloca, L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021542 · Cited by 270
Self-citationMechanisms of the placebo response
Benedetti, F., & Amanzio, M. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.01.006 · Cited by 93
Self-citationMind matters: placebo enhances reward learning in Parkinson's disease
Schmidt, L., Braun, E. K., Wager, T. D., & Shohamy, D. (2014) · Nature Neuroscience · doi:10.1038/nn.3842 · Cited by 84
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning
Frisaldi, E., Carlino, E., Zibetti, M., Barbiani, D., Dematteis, F., Lanotte, M., Lopiano, L., & Benedetti, F. (2017) · Movement Disorders · doi:10.1002/mds.27142 · Cited by 35
“These sequence effects have been demonstrated many times in studies uncovering the neurobiological underpinnings of the placebo response in PD.(14-17) In future clinical trials, it will be important to assess the history of previous treatments as well as to avoid, whenever possible, protocols involving exposure to unb…”
BackgroundSelf-citation
Metadata
- Authors
- Benedetti, F., Lanotte, M., Colloca, L., Ducati, A., Zibetti, M., & Lopiano, L.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2009-07-30
- Volume
- 587
- Issue
- 15
- Pages
- 3869-3883
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W1581585860
- Cited by
- 81
- References
- 11
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.